Abrol (ambroxol) SR tablets with prolonged release 75 mg. №20

Composition:

active ingredient: 1 tablet contains ambroxol hydrochloride 75 mg
excipients: hydroxypropyl methylcellulose, microcrystalline cellulose, magnesium stearate.

Indications.

Secretolytic therapy for acute and chronic bronchopulmonary diseases associated with a violation of bronchial secretion and a weakening of the passage of mucus.

Contraindications.

Abrol (ambroxol) SR should not be used in patients with known hypersensitivity to ambroxol hydrochloride or any of the other ingredients of the formulation.

Ambroxol SR 75 mg extended release tablets is not intended for use in children and adolescents.

Method of application and dose.

Unless otherwise indicated, the next dose of Abrol (ambroxol) SR is recommended.

Adults.

1 tablet 1 time per day (equivalent to 75 mg / day of ambroxol hydrochloride) in the morning or evening after meals. Tablets should be swallowed whole with plenty of water.

In general, there are no restrictions on the duration of use, but long-term therapy should be carried out under medical supervision.

Abrol SR should not be used for longer than 4-5 days without medical advice.

Children.

The drug should not be used in pediatric practice. Children are recommended to use ambroxol in the form of syrup 15 mg / 5 ml.